The content highlights an enterprise taxonomy focused on “AIPopulation and Public Health Analytics Care” and “Data and Information,” along with a mention of node settings to exclude the information from the Accelerate RSS feed.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
